The potent small molecule integrin antagonist THR-687 is a promising next-generation therapy for retinal vascular disorders
Hu, Tjing-Tjing, Vanhove, Marc, Porcu, Michaël, Van Hove, Inge, Van Bergen, Tine, Jonckx bart, Bart, Barbeaux, Philippe, Vermassen, Elke, Feyen, Jean H.M.Language:
english
Journal:
Experimental Eye Research
DOI:
10.1016/j.exer.2018.11.022
Date:
November, 2018
File:
PDF, 9.25 MB
english, 2018